The post‐transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase
暂无分享,去创建一个
D. Blaise | R. Clark | G. Meloni | A. Gratwohl | D. Niederwieser | J. Goldman | J. Reiffers | V. Rizzoli | J. Jouet | J. Apperley | A. Carella | A. van Biezen | J. Cahn | M. Michallet | E. Olavarría | A. Sureda | C. Boqué | Jane F. Apperley | Richard E Clark
[1] E. Olavarría. Autotransplantation for chronic myeloid leukemia: is it useful? , 2002, Haematologica.
[2] C. Vigouroux,et al. Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α , 2000, Leukemia.
[3] J. Melo,et al. The molecular biology of chronic myeloid leukemia. , 2000, Blood.
[4] A. Reiter,et al. Current trends in the management of chronic myelogenous leukemia , 2000, Annals of Hematology.
[5] A. Carella. Autografting with non-clonal mobilized hematopoietic progenitor cells in CML , 2000, Leukemia.
[6] C. Craddock,et al. High‐dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: a single‐centre experience , 2000, British journal of haematology.
[7] G. Li Pira,et al. Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft. , 2000, Experimental hematology.
[8] G. Meloni,et al. Chronic myeloid leukemia in first chronic phase not responding to α-interferon: outcome and prognostic factors after autologous transplantation , 1999, Bone Marrow Transplantation.
[9] C. Sawyers,et al. Tyrosine kinase inhibitors in chronic myeloid leukemia. , 1999, The cancer journal from Scientific American.
[10] F. Benvenuto,et al. Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. , 1999, Blood.
[11] R. Fanin,et al. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia. , 1999, Haematologica.
[12] G. Meloni,et al. Chronic myeloid leukemia in first chronic phase not responding to alpha-interferon: outcome and prognostic factors after autologous transplantation. EBMT Working Party on Chronic Leukemias. , 1999, Bone marrow transplantation.
[13] S. Sacchi,et al. Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] S. Forman,et al. Autologous transplantation for the treatment of chronic myelogenous leukemia. , 1998, Hematology/oncology clinics of North America.
[15] Carella. Autotransplants in Chronic Myeloid Leukemia. , 1998, The oncologist.
[16] N. Schmitz,et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998 , 1998, Bone Marrow Transplantation.
[17] I. Leukemia. Long term follow up of the italian trial of Interferon-A versus conventional chemotherapy in Chronic Myeloid Leukemia , 1998 .
[18] H. Heimpel,et al. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. , 1997, Journal of the National Cancer Institute.
[19] C Chastang,et al. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group. , 1997, The New England journal of medicine.
[20] J. Goldman. Treatment of chronic myeloid leukaemia: some topical questions. , 1997, Bailliere's clinical haematology.
[21] D. J. Van Den Berg,et al. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] C. Sawyers,et al. New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. , 1997, Haematologica.
[23] G. Daley. Rationalizing autotransplant strategies for chronic myeloid leukemia. , 1996, Leukemia & lymphoma.
[24] G. Gahrton,et al. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. , 1996, Bone marrow transplantation.
[25] P. Cony-Makhoul,et al. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia. , 1996, Bone marrow transplantation.
[26] M. Baccarani,et al. Interferon-alpha in the treatment of chronic myeloid leukemia. A summary and an update of the Italian studies. , 1996, Bone marrow transplantation.
[27] G. Gahrton,et al. Indications for haemopoietic precursor cell transplants in Europe , 1996, British journal of haematology.
[28] C. Verfaillie,et al. Autografting for chronic myelogenous leukemia , 1995, Current opinion in hematology.
[29] S. Richards,et al. UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response , 1995, The Lancet.
[30] G. Meloni,et al. Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT. , 1994, Bone marrow transplantation.
[31] J. Chang,et al. New strategies for the treatment of chronic myeloid leukemia. , 1994, Blood.
[32] Sutherland,et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. , 1994, Blood.
[33] A. Deisseroth,et al. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups , 1994, The Lancet.
[34] Sante Tura,et al. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. , 1994, The New England journal of medicine.
[35] R. Gray,et al. Autografting for patients with CML in chronic phase: an update , 1994, British journal of haematology.
[36] Goldman Jm. Autografting for CML--where does it fit in to the overall treatment strategy? , 1994 .
[37] G. Meloni,et al. Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMT. , 1994, Bone marrow transplantation.
[38] J. Goldman. Autografting for CML--where does it fit in to the overall treatment strategy? , 1994, Bone marrow transplantation.
[39] P. Mcglave. Autografting for chronic myelocytic leukemia. , 1994, Bone marrow transplantation.
[40] F. Frassoni,et al. Is there a place for autologous bone marrow transplantation in chronic myeloid leukemia? , 1993, Stem Cells.
[41] H. Heimpel,et al. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. , 1993, Blood.
[42] G. Daley,et al. Autologous transplant for CML revisited. , 1993, Experimental hematology.
[43] E. Canaani,et al. Chronic myelogenous leukemia: biology and therapy. , 1993, Leukemia.
[44] P. Mcglave. Unrelated donor and autologous marrow transplant therapy of chronic myelogenous leukemia (CML). , 1993, Leukemia.
[45] P. Cony-Makhoul,et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases , 1991, British journal of haematology.
[46] I. Cunningham. Bone marrow transplantation for chronic myelogenous leukemia. , 1990, Oncology.
[47] M. Vignetti,et al. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase. , 1989, Bone marrow transplantation.
[48] R. Gale,et al. Chronic myeloid leukemia. , 1992, The American journal of medicine.
[49] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] T. Ruutu,et al. Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast‐Cell Transformation , 1978, British journal of haematology.
[51] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .